Beta Bionics Inc (BBNX) financials
Beta Bionics revenue and earnings by year
Beta Bionics's revenue was $100 million in the fiscal year to December 31, 2025, up 53.9% from the year before. Net income was -$73.2 million, -73.0% of revenue. Since the fiscal year to December 31, 2022, revenue has grown 723.9% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 4 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 100 | 65 | 12 | 0 |
| Revenue growth | 53.9% | 442.9% | 6601.1% | — |
| Gross profit | 56 | 36 | 6 | — |
| Gross margin | 55.4% | 55.1% | 52.6% | — |
| Operating income | -72 | -45 | -36 | -66 |
| Operating margin | -71.5% | -69.5% | -298.9% | -36784.4% |
| Net income | -73 | -55 | -44 | -65 |
| Net margin | -73.0% | -84.1% | -367.6% | -36173.7% |
| Diluted EPS | -$1.81 | -$8.60 | — | — |
| Free cash flow | -56 | -52 | -33 | -61 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open BBNX in Markets.
See also: BBNX returns
No forecast, no recommendation. This page describes Beta Bionics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.